Is Pfizer Stock A Buy Or A Sell On Its Looming $43 Billion Seagen Takeover?

stock is under its key moving averages after the company announced its $43 billion plan to acquire Seagen (SGEN), a cancer specialist biotech.


Seagen makes antibody drug conjugates, or ADCs. These are toxic payloads directed to seek out specific targets on the outside of tumor cells. This limits their damage to surrounding, healthy tissue. By 2030, Pfizer…

This story appeared on, 2023-03-22.
The Web's Most Comprehensive Business News Site. Free to Use →